Corneal Injuries Clinical Trial
Official title:
Peri-operative Application of EYEPROTX General Anesthesia Protective Goggles as an Effective Modality to Reduce the Incidence of Corneal Injury Post-Intubation.
This is a randomized controlled trial that seeks to examine the effectiveness of Eyeprotx™ protective goggles in comparison to traditional methods against ocular injury that can occur perioperatively under general anesthesia.
Ocular injury is but a devastating condition that can occur perioperatively under general
anesthesia. Corneal abrasion is the most common ocular injury during general anesthesia,
surpassing case incidence of damage caused by patient movement in ophthalmologic surgery.
Causes of ocular injury include corneal drying due to the suppression of tear ducts from
anesthetic agents, direct physical trauma, or agitation from the volatile anesthetic used.
Ocular injury may also occur due to bacterial infection with MRSA, preventative methods, or
rubbing of the eyes postoperatively due to agitation. Agitation may be caused by corneal
drying or by shift or disruption in rapid eye movement sleep cycle from light penetration
through the eyelids. Attempts at prevention of corneal abrasion have been used, including
taping the eyelids shut, manual eye closure, paraffin-based ointment application into the
conjunctival sac, and the use of hydrophilic contact lenses, although only a few studies have
validated the comparison of these methods' effectiveness.
Eyeprotx™ Protective Goggles have been designed specifically for use in the operating room or
in any scenario where general anesthesia must be used, such as intubation in an emergency.
Current ocular protective measures such as tapes during anesthesia have been associated with
injury and infection. With this study, we hope to find a safer preventative technique against
ocular injury during the perioperative period.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03421548 -
Implantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1
|
N/A | |
Recruiting |
NCT05694247 -
Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness
|
N/A | |
Terminated |
NCT04485858 -
First in Human (FIH) Study to Assess Safety and Efficacy of the CorNeat KPro for the Treatment of Corneal Blindness
|
N/A | |
Recruiting |
NCT02948023 -
Stem Cells Therapy for Corneal Blindness
|
Phase 1 |